Biotech Values

[bellweather1]

Ariad/Macro-

Since it didn't hold the 10 level, are you looking for a bounce around the ema200(around 8)?

And how high?

I agree with pcrutch, that a large measure of reality(correlated with fear) is setting in concerning the broader market.

I think Ariad, on the other hand, is suffering more due to the contagious fear that's attached itself to all developmental biotechs, particularly post DNDN, as well as being a source of profitable institutional cash.

So what do your pitch forks tell you?

Best,

bw